Main Text

ICRP, 1987. Radiation dose to patients from radiopharmaceuticals. ICRP Publication 53. Ann. ICRP 18(1–4).

ICRP, 1991b. Radiation dose to patients from radiopharmaceuticals. Addendum 1 to ICRP Publication 53, in: Radiological protection in biomedical research. ICRP Publication 62. Ann. ICRP 22(3).

ICRP, 1998. Radiation dose to patients from radiopharmaceuticals. Addendum 2 to ICRP Publication 53. ICRP Publication 80. Ann. ICRP 28(3).

ARSAC, 2006. Notes for Guidance on the Clinical Administration of Radiopharmaceuticals and Use of Sealed Radioactive Sources. Administration of Radioactive Substances Advisory Committee, Health Protection Agency, UK.

Berg G. Nyström E. Jacobsson L. , 1998. Radioiodine treatment of hyperthyroidism in a pregnant woman. J. Nucl. Med. 39, 357–361.

Berman M. , 1977. Kinetic Models for Absorbed Dose Calculation. Medical Internal Radiation Committee (MIRD) Pamphlet No. 12. Society of Nuclear Medicine, New York, NY.

Bingham D. Gardin I. Hoyes K.P. , 2000. The problem of Auger emitters for radiological protection. Radiat. Prot. Dosim. 92, 219–228.

Bouchet L.G. Bolch W.E. Weber D.A. Atkins H.L. Poston J.W. Sr. , 1999. Radionuclide S-values in a revised dosimetric model of the adult head and brain. MIRD Pamphlet No. 15. J. Nucl. Med. 40, 62S–101S.

Cloutier R.J. Watson E.E. Rohrer R.H. Smith E.M. , 1973. Calculating the radiation dose to an organ. J. Nucl. Med. 14, 53–55.

Coffey J.L. Watson E.E. , 1979. Calculating doses from remaining body activity. A comparison of two methods. Med. Phys. 6, 307–308.

Feinendegen L.E. Neumann R.D. , 2004. Dosimetry and risk from low- versus high-LET radiation of Auger events and the role of nuclide carriers. Int. J. Radiat. Biol. 80, 813–822.

Gardin I. Faraggi M. Le Guludec D. Bok B. , 1999. Cell irradiation caused by diagnostic nuclear medicine procedures: Dose heterogeneity and biological consequences. Eur. J. Nucl. Med. 26, 1617–1626.

Gelfand M.J. Thomas S.R. Kereiakes J.G. , 1983. Absorbed radiation dose from routine imaging of the skeleton in children. Ann. Radiol. 26, 421–423.

Goddu S.M. Howell R.W. Rao D.V. , 1994. Cellular dosimetry: Absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J. Nucl. Med. 35, 303–316.

Goddu S.M. Howell R.W. Bouchet L.G. Bolch W.E. Rao D. , 1997. MIRD Cellular S Values. Society of Nuclear Medicine, Inc, Reston, VA.

Hofer K.G. , 1996. Biophysical aspects of Auger processes. A review. Acta Oncol. 35, 789–796.

IAEA, 2006. Quality Assurance for Radioactivity Measurement in Nuclear Medicine. Technical Report Series No. 454. International Atomic Energy Agency, Vienna.

ICRP, 1971. Protection of the Patient in Radionuclide Investigations. ICRP Publication 17. Pergamon Press, Oxford.

ICRP, 1973. Alkaline Earth Metabolism in Adult Man. ICRP Publication 20. Pergamon Press, Oxford.

ICRP, 1977. Recommendations of the International Commission on Radiological Protection. ICRP Publication 26. Pergamon Press, Oxford.

ICRP, 1979. Limits for intakes of radionuclides by workers. ICRP Publication 30, Part 1. Ann. ICRP 2(3/4).

ICRP, 1980. Limits for intakes of radionuclides by workers. ICRP Publication 30, Part 2. Ann. ICRP 4(3/4).

ICRP, 1981. Limits for intakes of radionuclides by workers. ICRP Publication 30, Part 3. Ann. ICRP 6(2/3).

ICRP, 1987. Radiation dose to patients from radiopharmaceuticals. ICRP Publication 53. Ann. ICRP 18(1–4).

ICRP, 1991a. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21(1–3).

ICRP, 1991b. Radiation dose to patients from radiopharmaceuticals. Addendum 1 to ICRP Publication 53. ICRP Publication 62. Ann. ICRP 22(3).

ICRP, 1993. Age-dependent doses to members of the public from intake of radionuclides. Part 2: Ingestion dose coefficients. ICRP Publication 67. Ann. ICRP 23(3/4).

ICRP, 1994. Dose coefficients for intake of radionuclides by workers. ICRP Publication 68. Ann. ICRP 24(4).

ICRP, 1996. Age-dependent doses to members of the public from intake of radionuclides. Part 5. ICRP Publication 72. Ann. ICRP 26(1).

ICRP, 1998. Radiation dose to patients from radiopharmaceuticals. Addendum 2 to ICRP Publication 53. ICRP Publication 80. Ann. ICRP 28(3).

ICRP, 2001a. Doses to the embryo and fetus from intake of radionuclides by the mother. ICRP Publication 88. Ann. ICRP 31(1–3).

ICRP, 2003. Relative biological effectiveness (RBE), quality factor (Q) and radiation weighting factor (w _R ). ICRP Publication 92. Ann. ICRP 33(4).

ICRP, 2004. Doses to infants from ingestion of radionuclides in mothers' milk. ICRP Publication 95. Ann. ICRP 34(3/4).

ICRP, 2007. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann. ICRP 37(1–3).

ICRU, 1979. Methods of Assessment of Absorbed Dose in Clinical Use of Radionuclides. ICRU Report 32. International Commission on Radiation Units and Measurements, Bethesda, MD.

ICRU, 2002. Absorbed-dose specification in nuclear medicine. ICRU Report 67. J. ICRU 2, 1–110.

Johansson L. Mattsson S. Nosslin B. Leide-Svegborn S. , 1992. Effective dose from radiopharmaceuticals. Eur. J. Nucl. Med. 19, 933–938.

Jönsson L. Ljungberg M. Strand S.E. , 2005. Evaluation of accuracy in activity calculations for the conjugate view method from Monte Carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom. J. Nucl. Med. 46, 1679–1686.

Kassis A.M. , 2004. The amazing world of Auger electrons. Int. J. Radiat. Biol. 80, 789–903.

Kaul A. Krauss O. Petrausch G. , 1985. Strahlenexposition durch Tc-99m-Methylendiphosphonat — lokale Dosisverteilung in Wachstum zonen des kindlichen Skelett und Organdosen. In: Poretti G. (Ed.), Medizinische Physik. Deutsche Gesellschaft für medizinische Physik, Bern.

Loevinger R. Berman M. , 1968. A schema for absorbed-dose calculations for biologically distributed radionuclides. MIRD Pamphlet No. 1. J. Nucl. Med. 9 (Suppl. 1), 7–14.

Loevinger R. Budinger T.F. Watson E.E. , 1991. MIRD Primer for Absorbed Dose Calculations. Revised edition. Society of Nuclear Medicine, New York, NY.

NCRP, 1982. Nuclear Medicine — Factors Influencing the Choice and Use of Radionuclides in Diagnosis and Therapy. NCRP Report No. 70. National Council on Radiation Protection and Measurements, Bethesda, MD.

NCRP, 1985. General Concepts for the Dosimetry of Internally Deposited Radionuclides. NCRP Report No. 84. National Council on Radiation Protection and Measurements, Bethesda, MD.

Norrgren K. Svegborn S.L. Areberg J. Mattsson S. , 2003. Accuracy of the quantification of organ acticity from planar gamma camera images. Cancer Biother. Radiopharm., 18.

Roedler H.D. , 1980. Accuracy of Internal Dose Calculations with Special Consideration of Radiopharmaceutical Biokinetics. Third International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN. HHS Publication (FDA 81-8166). Department of Health and Human Welfare, Bureau of Radiological Health, Rockville, MD.

Roedler H.D. Kaul A. , 1976. Dose to Target Organs from Remaining Body Activity: Results of the Formally Exact and Approximate Solution. Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN. HEW Publication (FDA 76-8044). pp. 155–163.

Roedler H.D. Kaul A. Hine G.J. , 1978. Internal Radiation Dose in Diagnostic Nuclear Medicine. Hoffman, Berlin.

Russell J.R. Stabin M.G. Sparks R.B. Watson E.E. , 1997. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. J. Nucl. Med. 73, 756–769.

Snyder W.S. Ford M.R. Warner G.G. , 1978. Estimates of Specific Absorbed Fractions for Photon Sources Uniformly Distributed in Various Organs of a Heterogeneous Phantom. Medical Internal Radiation Dose Committee (NM/MIRD) Pamphlet No. 5, revised. Society of Nuclear Medicine, New York, NY.

Snyder W.S. Ford M.R. Warner G.G. Fisher H.R. Jr , 1969. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. MIRD Pamphlet No. 5. J. Nucl. Med. 10 (Suppl. 3).

Snyder W.S. Ford M.R. Warner G.G. Watson S.B. , 1975. “S” Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs. MIRD Pamphlet No. 11. Society of Nuclear Medicine, New York, NY.

Stabin M.G. , 1996. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med. 37, 538–546.

Stabin M.G. Sparks R.B. Crowe E. , 2005. OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med. 46, 1023–1027.

Stepanek J. Larsson B. Weinreich R. , 1996. Auger-electron spectra of radionuclides for therapy and diagnostics. Acta Oncol. 35, 863–868.

Taylor D.M. , 2000c. Subcellular distribution of gallium-67 and other Auger-emitting radionuclides in human and animal tissues. Radiat. Prot. Dosim. 92, 229–231.

Watson E.E. Stabin M.G. Eckerman K.F. , 1989. A model of the peritoneal cavity for use in internal dosimetry. J. Nucl. Med. 30, 2002–2011.

Winchell H.S. Horst W.D. Braun L. Oldendorf W.H. Hattner R. Parker H. , 1980. N-Isopropyl (¹²³I)p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localisation in dog and monkey brain. J. Nucl. Med. 21, 947–952.

Zanzonico P.B. , 2000. Internal radionuclide radiation dosimetry: A review of basic concepts and recent developments. J. Nucl. Med. 41, 297–308.